Nucleic acid composition, kit and method for simultaneously detecting multiple mutant strains of SARS-CoV-2

A nucleic acid composition and coronavirus technology, which is applied in the field of nucleic acid detection, can solve the problems of inconvenient virus monitoring and disease treatment, and the inability to quickly detect new coronaviruses, and achieve stable and reliable detection results, stable and reliable experimental results, and cost-saving detection. Effect

Active Publication Date: 2022-01-07
SHENZHEN ZIJIAN BIOTECH
View PDF7 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The inventor found that the existing virus detection methods can only detect a single mutant strain, and cannot rapidly detect the novel coronavirus (SARS-CoV-2) Alpha, Beta, Gamma, Eta, Delta, lota, Kappa, Lambda mutant strains at the same time , which brings a lot of inconvenience to virus monitoring and disease treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid composition, kit and method for simultaneously detecting multiple mutant strains of SARS-CoV-2
  • Nucleic acid composition, kit and method for simultaneously detecting multiple mutant strains of SARS-CoV-2
  • Nucleic acid composition, kit and method for simultaneously detecting multiple mutant strains of SARS-CoV-2

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] A nucleic acid composition for simultaneously detecting multiple mutant strains of novel coronavirus

[0068] Synthetic primers and probes were designed for the nucleic acid sequences of the eight mutants:

[0069] According to the nucleic acid sequences of the new coronavirus (SARS-CoV-2) Alpha, Beta, Gamma, Eta, Delta, lota, Kappa, Lambda mutant strains published by NCBI, eleven sets of specific primers were designed using Oligo7.0 primer design software and probe. The sequences of primers and probes are shown in Table 1.

[0070] Table 1 Eleven sets of primer probe sequences

[0071]

[0072]

[0073]

[0074]

[0075] The 5' end of each probe sequence is modified with a fluorescent reporter group, and the 3' end of each probe sequence is modified with a fluorescent quencher group. Wherein, the fluorescent reporting group is selected from one of FAM, JOE, VIC, HEX, ROX, TEXAS RED and CY5, and the fluorescent quenching group is selected from one of BHQ1...

Embodiment 2

[0081] A kit for simultaneously detecting multiple mutant strains of novel coronavirus

[0082] One or more of the novel coronavirus (SARS-CoV-2) Alpha, Beta, Gamma, Eta, Delta, lota, Kappa, and Lambda mutant strains published by NCBI can be detected simultaneously.

[0083] The kit includes the following reagents: primers and probes for one or several sites in the nucleic acid composition obtained in Example 1; enzyme mixture; PCR reaction reagents.

[0084] The enzyme mixture includes DNA polymerase, reverse transcriptase, and Rnasin. The DNA polymerase is a hot-start Taq enzyme, and the reverse transcriptase includes c-MMLV reverse transcriptase or AMV reverse transcriptase. In this example, c-MMLV reverse transcriptase is used.

[0085] The PCR reaction reagents include PCR buffer, dNTPs and cations, the PCR buffer is 10×PCR Buffer, and the cations are derived from MgCl 2 .

[0086] Preparation of reagents: take reaction solutions Ⅰ, Ⅱ, Ⅲ, Ⅳ: N×19 μL; enzyme mixture: N×1...

Embodiment 3

[0102] A method for simultaneously detecting multiple mutant strains of novel coronavirus, comprising the following steps:

[0103] S1. Collect and extract the RNA of the test sample:

[0104] For sample collection, refer to the throat swab or sputum collection method in the "Technical Guidelines for Laboratory Testing of Novel Coronavirus Pneumonia".

[0105] Pharyngeal swab sample: Pass the swab over the base of the tongue, wipe the pharyngeal tonsils on both sides of the subject with a little force back and forth, and then wipe up and down the back wall of the pharynx, dip the swab head into the tube containing the virus preservation solution, and discard the tail. Tighten the tube cap.

[0106] Sputum sample: After the patient coughs deeply, collect the coughed up sputum into a tube containing virus preservation solution, and tighten the cap of the tube tightly.

[0107] In this embodiment, the throat swab collection method is adopted.

[0108] A nucleic acid extraction...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of nucleic acid detection, and particularly discloses a nucleic acid composition, a kit and a method for simultaneously detecting multiple mutant strains of SARS-CoV-2. The SARS-CoV-2 comprises a wild type and Alpha mutant strain, a Beta mutant strain, a Gamma mutant strain, an Eta mutant strain, a Delta mutant strain, a lota mutant strain, a Kappa mutant strain and a Lambda mutant strain, and the design sites of a primer probe composition comprise N gene, RNase P gene and S gene N501Y, E484K, K417T, L452R, E484Q, F490S, T76I, L452Q and 246-253del mutant types. The nucleic acid composition, the kit and the method disclosed by the invention can be used for simultaneously and rapidly detecting the SARS-CoV-2 and the main epidemic mutant strain thereof, and have the advantages of high sensitivity and good specificity.

Description

technical field [0001] The present application relates to the field of nucleic acid detection, more specifically, it relates to a nucleic acid composition, kit and method for simultaneously detecting multiple mutant strains of novel coronavirus. Background technique [0002] The International Committee on Taxonomy of Viruses named the new coronavirus disease SARS-CoV-2, which is the seventh known coronavirus that can infect humans, and the third discovered after SARS-CoV and MERS-CoV that can cause human infection. Coronaviruses for severe acute respiratory disease. SARS-CoV-2 is a single-stranded positive-strand RNA virus, which is prone to errors in the replication process, and a large number of replications can cause multiple mutations. Once a mutant strain with good adaptability appears, it may cause widespread spread, which brings certain risks to virus surveillance. The mutant strains currently released by NCBI include the following types: Alpha, Beta, Gamma, Eta, De...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/70C12N15/11C12Q1/6851C12R1/93
CPCC12Q1/701C12Q1/6851C12Q2600/16C12Q2561/113C12Q2563/107C12Q2537/143C12Q2531/113Y02A50/30
Inventor 马力敏汪洋杨海芳蔡昆于洪波
Owner SHENZHEN ZIJIAN BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products